Company intelligence / Profile preview

NeoMed

Ownership: Private
Development stage: Other

Overview

NeoMed is an international venture capital and private equity investment group exclusively focused on healthcare and life science. It invests in early-stage companies with high growth potential in biotech, pharma, medtech, and related sectors. The company has established multiple funds totaling over $200 million in committed capital since its founding in 1996. It is based in Oslo, Norway but invests internationally.

Industry: Investors

Partnerships

Portfolio investments include InDex Pharmaceuticals and others

Beyond the preview

Go deeper on NeoMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeoMed.

Explore the full profile